Adaptive Biotechnologies

129 articles with Adaptive Biotechnologies

• Adaptive Biotechnologies Aims for $20 Million Funding Round

  7/16/2013

• Adaptive Biotechnologies and Biogen Idec, Inc. (Massachusetts) Sign Immunological Services Agreement

  6/27/2013

• Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement With Bristol-Myers Squibb Company

  5/9/2013

• Adaptive Biotechnologies Launches Clonoseq, a More Sensitive, Accurate Assay to Detect Minimal Residual Disease (MRD) in Blood-Based Cancers.

  12/7/2012

• New Study Shows Adaptive Biotechnologies ImmunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia

  5/17/2012

• Adaptive TCR Corporation Changes Name to Adaptive Biotechnologies

  1/3/2012

• Adaptive TCR Corporation Raises $5.8 Million in Series B Funding to Expand ImmunoSEQ Platform and Focus on Clinical Applications

  6/10/2011

• Adaptive TCR Corporation Launches the immunoSEQ(TM) Product Line - Visualizing the Immune System With Next-Generation Sequencing

  10/21/2010

• Adaptive TCR Corporation, a Fred Hutchinson Cancer Research Center Spinoff, Nabs $4.5M to Uncover Immune System Secrets

  3/26/2010